Simplex Trading
NPCE icon

Simplex Trading’s Neuropace NPCE Stock Holding History

Simplex Trading’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,895
Closed -$17.9K – 9724
2025
Q2 		$21K Buy
1,895
+1,834
+3,007% +$22.9K ﹤0.01% 6732
2025
Q1 		$0 Buy
61
+25
+69% +$313 ﹤0.01% 9273
2024
Q4 		$0 Buy
+36
New +$313 ﹤0.01% 9275
2024
Q3 		– Sell
-370
Closed -$2K – 9214
2024
Q2 		$2K Buy
+370
New +$3.73K ﹤0.01% 8316

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Simplex Trading's NPCE Position: Q3 2025 in Review

Simplex Trading sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 1,895 shares — an estimated $17.9K sold.

Simplex Trading first reported a position in NPCE in Q2 2024 and held it in 4 quarters. The position peaked at $21K in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

  • Simplex Trading reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 1,895 Neuropace shares in Q3 2025, an estimated $17.9K.
  • Simplex Trading first reported a position in Neuropace in Q2 2024 and held it in 4 quarters.
  • Simplex Trading's Neuropace position peaked at $21K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.